Retour
Prix Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)
Graphique du cours de l'action 2315.HK
BIOCYTOGEN-B (2315.HK)
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
HK$43.28
-0.55%
$-0.24
Marché fermé: Jan 16, 16:00:00 HKT
Statistiques clés
Clôture préc.
$43
Prix d'ouverture
$43.52
Plage de la journée
$41 - $43.88
Plage de 52 semaines
$7.25 - $48.26
Volume
657.0K
Volume moyen
1.0M
BPA (TTM)
0.37
Rendement en dividend
--
Capitalisation boursière
$4.6B
Qu’est-ce que BIOCYTOGEN-B ?
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. manufactures biological products and provides related biological services. The company is headquartered in Beijing, Beijing and currently employs 1,306 full-time employees. The company went IPO on 2022-09-01. The firm utilizes its self-developed RenMice fully human antibody and T-cell receptor (TCR) mouse platform for large-scale drug discovery and development targeting potential drug targets in the human body. The Company’s main businesses include the sale of innovative animal models, pre-clinical pharmacology and efficacy evaluation services, and antibody development. The firm is also engaged in the provision of gene-editing services. The firm operates its businesses in the domestic market and overseas markets.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved
